These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27097292)

  • 1. Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection.
    Neugebauer S; Giamarellos-Bourboulis EJ; Pelekanou A; Marioli A; Baziaka F; Tsangaris I; Bauer M; Kiehntopf M
    Crit Care Med; 2016 Sep; 44(9):1649-62. PubMed ID: 27097292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity.
    Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z
    Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?
    Dremsizov T; Clermont G; Kellum JA; Kalassian KG; Fine MJ; Angus DC
    Chest; 2006 Apr; 129(4):968-78. PubMed ID: 16608946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated partial thromboplastin time waveform analysis: a new tool to detect infection?
    Chopin N; Floccard B; Sobas F; Illinger J; Boselli E; Benatir F; Levrat A; Guillaume C; Crozon J; Négrier C; Allaouchiche B
    Crit Care Med; 2006 Jun; 34(6):1654-60. PubMed ID: 16607236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock.
    Artero A; Zaragoza R; Camarena JJ; Sancho S; González R; Nogueira JM
    J Crit Care; 2010 Jun; 25(2):276-81. PubMed ID: 20149587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
    Zhao Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site of infection and mortality in patients with severe sepsis or septic shock. A cohort study of patients admitted to a Danish general intensive care unit.
    Klastrup V; Hvass AM; Mackenhauer J; Fuursted K; Schønheyder HC; Kirkegaard H;
    Infect Dis (Lond); 2016 Oct; 48(10):726-31. PubMed ID: 27389656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar Metabolic, Innate Immunity, and Adipokine Profiles in Adult and Pediatric Sepsis Versus Systemic Inflammatory Response Syndrome-A Pilot Study.
    Tavladaki T; Spanaki AM; Dimitriou H; Kondili E; Choulaki C; Georgopoulos D; Briassoulis G
    Pediatr Crit Care Med; 2017 Nov; 18(11):e494-e505. PubMed ID: 28816920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis-associated changes of the arachidonic acid metabolism and their diagnostic potential in septic patients.
    Bruegel M; Ludwig U; Kleinhempel A; Petros S; Kortz L; Ceglarek U; Holdt LM; Thiery J; Fiedler GM
    Crit Care Med; 2012 May; 40(5):1478-86. PubMed ID: 22511130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].
    Dong Z; Jianxin Z; Haraguchi G; Arai H; Mitaka C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):478-9. PubMed ID: 25163104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.
    Brunkhorst FM; Wegscheider K; Forycki ZF; Brunkhorst R
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S148-52. PubMed ID: 18470710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units].
    Průcha M; Herold I; Zazula R; Dubská L; Kavka B; Dostál M
    Vnitr Lek; 2003 Jul; 49(7):541-7. PubMed ID: 12931436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
    Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes.
    Chang Y; Yoo HJ; Kim SJ; Lee K; Lim CM; Hong SB; Koh Y; Huh JW
    Crit Care; 2023 Jul; 27(1):263. PubMed ID: 37408042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
    Liu Z; Yin P; Amathieu R; Savarin P; Xu G
    Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated nucleosome levels in systemic inflammation and sepsis.
    Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
    Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
    Yin Q; Liu B; Chen Y; Zhao Y; Li C
    Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.
    Zahar JR; Timsit JF; Garrouste-Orgeas M; Français A; Vesin A; Descorps-Declere A; Dubois Y; Souweine B; Haouache H; Goldgran-Toledano D; Allaouchiche B; Azoulay E; Adrie C
    Crit Care Med; 2011 Aug; 39(8):1886-95. PubMed ID: 21516036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.